Genetic, Psychological, and Behavioural Factors Associated with Subtypes of Pain-Related Temporomandibular Disorders
- PMID: 40868215
- PMCID: PMC12383287
- DOI: 10.3390/biomedicines13081961
Genetic, Psychological, and Behavioural Factors Associated with Subtypes of Pain-Related Temporomandibular Disorders
Abstract
Background: This genetic association study investigated single nucleotide polymorphism (SNP) in interleukin-8 (CXCL8) and opiorphin (OPRPN) genes, as well as psychological characteristics and oral behaviours, between patients with pain-related temporomandibular disorders (TMDp) and healthy controls. The aim was to examine associations and predictive value of these factors for TMDp subtypes: arthralgia and myalgia. Methods: A total of 85 patients with TMDp (arthralgia and/or myalgia) and 85 pain-free controls were included. Diagnoses were established following the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). All participants completed standardised self-report questionnaires assessing anxiety, depression, and oral behaviours. Buccal swabs were collected for DNA extraction, and SNP genotyping was performed using real-time PCR. Statistical analyses were conducted using dominant and recessive genetic models. Logistic regression models were applied to assess risk factors for each TMDp subtype. Results: Participants homozygous for the minor allele (CC genotype) of rs1387964 in OPRPN were significantly more prevalent in both arthralgia and myalgia groups compared to controls. Age and female sex predicted TMDp-arthralgia. Predictors of TMDp-myalgia included the CC genotype of rs1387964, age, female sex, anxiety, and depression. Conclusions: Genetic background and psychological characteristics were significant predictors of TMDp myalgia, highlighting a multifactorial profile for this TMDp subtype.
Keywords: arthralgia; biomarkers; chronic pain; myalgia; single nucleotide polymorphism; temporomandibular joint disorders.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Association of oral behaviours and psychological factors with selected genotypes in pain-related TMD.Oral Dis. 2024 Apr;30(3):1702-1715. doi: 10.1111/odi.14583. Epub 2023 Apr 10. Oral Dis. 2024. PMID: 37036392
-
Psychological therapies for the management of chronic and recurrent pain in children and adolescents.Cochrane Database Syst Rev. 2018 Sep 29;9(9):CD003968. doi: 10.1002/14651858.CD003968.pub5. Cochrane Database Syst Rev. 2018. PMID: 30270423 Free PMC article.
-
Distribution of anxiety and depression among different subtypes of temporomandibular disorder: A systematic review and meta-analysis.J Oral Rehabil. 2022 Jul;49(7):754-767. doi: 10.1111/joor.13331. Epub 2022 Apr 22. J Oral Rehabil. 2022. PMID: 35398904
-
Psychological therapies for temporomandibular disorders (TMDs).Cochrane Database Syst Rev. 2022 Aug 11;8(8):CD013515. doi: 10.1002/14651858.CD013515.pub2. Cochrane Database Syst Rev. 2022. PMID: 35951347 Free PMC article.
-
Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.Clin Oral Investig. 2024 Apr 9;28(5):246. doi: 10.1007/s00784-024-05653-y. Clin Oral Investig. 2024. PMID: 38589630
References
-
- Schiffman E., Ohrbach R., Truelove E., Look J., Anderson G., Goulet J.P., List T., Svensson P., Gonzalez Y., Lobbezoo F., et al. International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J. Oral Facial Pain Headache. 2014;28:6–27. - PMC - PubMed
-
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
-
- Smith S.B., Mir E., Bair E., Slade G.D., Dubner R., Fillingim R.B., Greenspan J.D., Ohrbach R., Knott C., Weir B., et al. Genetic variants associated with development of TMD and its intermediate phenotypes: The genetic architecture of TMD in the OPPERA prospective cohort study. J. Pain. 2013;14:91–101. doi: 10.1016/j.jpain.2013.09.004. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources